A new class of weight loss drugs is powering massive stock-market gains for Novo Nordisk and Eli Lilly

Eli Lilly now sports a market valuation of about $500 billion, making it the ninth largest US company by market capitalization.

Related Keywords

United States ,America ,Eli Lilly Mounjaro ,Geoff Meacham ,Eli Lilly ,Novo Nordisk Wegovy ,Sachin Jain ,Novo Nordisk ,Market Valuation ,Weight Loss Drug ,Pharmaceutical Companies ,Weight Loss ,Stock Market ,Overweight Patients ,